We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
-6.98%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$431M
(-62%)
Cap. Flow
-$403M
Cap. Flow
% of AUM
-152.44%
Top 10 Holdings %
Top 10 Hldgs %
27.43%
Holding
286
New
68
Increased
19
Reduced
60
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$9.98M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
+$4.39M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.85M |
| 4 |
Boston Scientific
BSX
|
+$3.16M |
| 5 |
Pfizer
PFE
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$16M |
| 2 |
AbbVie
ABBV
|
+$15.9M |
| 3 |
Zoetis
ZTS
|
+$13.5M |
| 4 |
PepsiCo
PEP
|
+$12.8M |
| 5 |
McKesson
MCK
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.36% |
| 2 | Consumer Discretionary | 7.36% |
| 3 | Industrials | 6.49% |
| 4 | Technology | 4.09% |
| 5 | Financials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
126
DELISTED
Vector Group Ltd.
VGR
| $463K | 0.18% |
35,110
-53,531
| -60% | -$723K |
|
|
DMND
127
PUT
DELISTED
DIAMOND FOODS, INC.
DMND
| $463K | 0.18% |
+15,000
| New | +$470K |
|
128
MGM Resorts International
MGM
$11.7B
| $450K | 0.17% |
24,390
-81,534
| -77% | -$1.63M |
|
|
GNMK
129
DELISTED
GenMark Diagnostics, Inc
GNMK
| $433K | 0.16% |
55,000
-20,000
| -27% | -$185K |
|
130
Compass Minerals
CMP
$1.25B
| $430K | 0.16% |
5,492
-9,191
| -63% | -$754K |
|
131
Vanda Pharmaceuticals
VNDA
$312M
| $395K | 0.15% |
35,000
-25,000
| -42% | -$306K |
|
|
HMHC
132
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $382K | 0.14% |
18,814
-103,415
| -85% | -$2.47M |
|
|
GWR
133
DELISTED
Genesee & Wyoming Inc.
GWR
| $381K | 0.14% |
+6,446
| New | +$444K |
|
|
CHK
134
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $367K | 0.14% |
+250
| New | +$425K |
|
135
Huntington Ingalls Industries
HII
$12.6B
| $356K | 0.13% |
+3,319
| New | +$378K |
|
|
DMND
136
DELISTED
DIAMOND FOODS, INC.
DMND
| $336K | 0.13% |
+10,889
| New | +$341K |
|
137
UnitedHealth
UNH
$383B
| $325K | 0.12% |
2,800
-37,200
| -93% | -$4.45M |
|
138
CALL
Globalstar
GSAT
$10.3B
| $314K | 0.12% |
+13,333
| New | +$376K |
|
139
Axalta
AXTA
$7.71B
| $308K | 0.12% |
12,138
-28,587
| -70% | -$849K |
|
140
PPG Industries
PPG
$25B
| $299K | 0.11% |
3,411
-36,428
| -91% | -$3.71M |
|
141
Zebra Technologies
ZBRA
$13.7B
| $284K | 0.11% |
+3,707
| New | +$350K |
|
142
Martin Marietta Materials
MLM
$32.4B
| $281K | 0.11% |
1,849
-1,989
| -52% | -$322K |
|
|
PETX
143
DELISTED
Aratana Therapeutics, Inc.
PETX
| $254K | 0.1% |
+30,000
| New | +$508K |
|
144
Sally Beauty Holdings
SBH
$1.46B
| $253K | 0.1% |
+10,658
| New | +$295K |
|
|
HDP
145
DELISTED
Hortonworks, Inc.
HDP
| $199K | 0.08% |
9,112
-53,438
| -85% | -$1.33M |
|
146
Agnico Eagle Mines
AEM
$75.4B
| $175K | 0.07% |
+6,897
| New | +$168K |
|
|
B
147
Barrick Mining
B
$63.2B
| $125K | 0.05% |
+19,730
| New | +$148K |
|
148
Fortune Brands Innovations
FBIN
$5.88B
| $104K | 0.04% |
+2,572
| New | +$106K |
|
|
FENX
149
DELISTED
Fenix Parts, Inc.
FENX
| $72K | 0.03% |
10,811
-29,189
| -73% | -$274K |
|
150
PVH
PVH
$4.01B
| $34K | 0.01% |
332
-2,480
| -88% | -$282K |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Catapult Capital Management held 286 positions worth $265M, down 62% from $696M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Catapult Capital Management withdrew a net $403M in Q3 2015, closing 135 positions and reducing 60 holdings. Its most notable exit was PepsiCo, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Vertex Pharmaceuticals worth $3.12M.
- Catapult Capital Management's largest Q3 2015 buy was Vertex Pharmaceuticals: 30,000 shares worth $3.12M.
- Catapult Capital Management added most to Allergan plc in Q3 2015, an estimated $9.98M increase.
- Catapult Capital Management's biggest Q3 2015 reduction was CVS Health, cutting an estimated $16M.
- Catapult Capital Management fully exited PepsiCo in Q3 2015, selling an estimated $12.8M.
- Catapult Capital Management's ten largest holdings make up 27% of its $265M portfolio in Q3 2015.
- Catapult Capital Management opened 68 new positions and closed 135 in Q3 2015.
- Catapult Capital Management's portfolio value fell 62% quarter-over-quarter to $265M.
Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.